Mutation detail:
| Mutation site | 27861G>A |
| Virus | SARS-CoV-2 |
Mutation level  |
Nucleotide level |
| Gene/protein/region type | ORF7b |
| Gene ID | 43740574 |
| Country | - |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | MN908947.3 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | ORF7b |
| Uniprot protein ID | - |
| Protein length | 43 amino acids |
| Protein description | ORF7b encodes a viral accessory protein. Based on its similarity to other coronavirus proteins, ORF7b protein is thought to localize to the Golgi compartment. The orf7b is a hydrophobic protein with a transmembrane domain N-terminal at the outside, and a cytoplasmic C-terminal. Similar to orf7a, orf7b is reported by the majority of the previous studies that it is not essential for virus replication. |
Literature information:
| Pubmed ID | 33239633 |
| Clinical information | No |
| Disease | - |
| Published year | 2020 |
| Journal | Nature Communications |
| Title | No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 |
| Author | Lucy van Dorp, Damien Richard, Cedric C S Tan, Liam P Shaw, Mislav Acman |
| Evidence | Supplementary Data1 |